EFTA02594854.pdf

From: jeffrey E. <[email protected]> Sent: Sunday, November 16, 2014 9:41 AM To: Joi Ito Subject: Re: GPCR we should just know ore about 2nd round, so we are not dil=ted On =at, Nov 15, 2014 at 6:52 PM, Joi Ito • wrot=: Mo=e background on the science. The investment vehicle is basically a holding=company for the technology that will spin out in various applications incl=ding biomedical, etc. Jeffrey, this is being done in Ne=l Gershenfeld's Lab, CBA. -Joi Begin forwarded message: =br> Hi Joi,<=iv style="font-family:Helvetica;font-size:12px;font-style:normal;font-variant:normal;font- weight:normal;letter-spacing:normal;line-height:normal;te=t-align:starttext-indent:0px;text-transform:none;white- space:normal;word-=pacing:0px"> I just hired a new postdoc dedicated f=r this odorant-receptor-based sensor project. He just arrived last w=ek. However, I will ask Dr. Andreas Mershin if his polymer smelling =evice is good to give a try. Ou= water-soluble GPCR project got a big breakthrough last week. Here i= a deck of slides and message I wrote to Teijin Head of Strucutral Biology= I visited there and gave a talk on Wednesday. I just return to Bost=n last night. Dann= Hillis will invest in OH2Laboratories. He was here visiting =e and very excited. Shu uan Zhan «= hrefr"maiRo: ar et=" blank" <mailto : David, Marc Rioult Re: Thank you =ear Midori, I was very pleased to meet you again yesterday=at Teijin. This was my 4th time visiting Teijin. =div style="font-family:ArialMT"> Please find the attached slides of my talk at Teijin yesterday. =ope you can understand our recent breakthrough to design water-soluble GPC=s and all other membrane proteins as well as all aggregated proteins.4,=A0 EFTA_R1_01779011 EFTA02594854  I am very pleased that you are very interested in taking a su=-licensing of our invention. Dr. David Levy, the Managing Director o= OH2Laboratories and Dr. Marc Rioult, former MIT TLO Senior Officer will t=ke lead on the negotiation. They are very experts. Dr. David Levy r=ceived all his 3 degrees, BS, MS and Ph.D. from MIT with Prof. Alex Slocum=of Mechanical Engineering. Dr. David =evy who was the 1996 student Lemelson Prize winner. He worked at App=e Computer in 1980s. He designed the first Apple laptop computer tra=k pad, now it is on every single laptop computer. http://en.w=kipedia.org/wiki/David_Levy_(inventor) chttp:/=en.wikipedia.org/wiki/David_Levy_(inventor)>, http://en.wikipedia.org/wiki/Lemelson*=93MIT_Prize#1996 <http://en.wikipedia.org/wiki/Lemelson%E2%80%93MI=_Prize#1996> =br> Dr. David Levy raises funding to carry =ut my frontier research and invention of a universal protein engineering c=de, I call it QTY Code. Not only this work will have big impact to g=nerate new knowledge, but it will also accelerate drug discovery and truly=personalized medicine. Please see the interview of L=ta Nelsen, the Director of MIT Technology Licensing Office: =a href="http://newsoffice.mit.edu/2014/3-questions-lita-nelsen-technolog=-Iicensing-office-1107" target="_blank">http://newsoffice.mit.edu/2014/3=questions-lita-nelsen-technology-licensing-office-1107 <=r> Here is the photo from yesterda=. =/div> Shuguang On Nov 14, 2014, at 3:53 PM, =oi Ito mailto > wrote: Is your artificial nose ready to test on wine? :-) Btw, I a= contacting some possible angel investors for your research. Please u h= mail for nfidential mail only. For general Media Lab email, please us= =a> <mailto 2 EFTA_R1_01779012 EFTA02594855  =C24, please note The information contained in this communic=tion is confidential, may be attorney-client privileged, may constit=te inside information, and is intended only for the use of the addresse=. It is the property of JEE Unauthorized use, disclosure or copying =f this communication or any part thereof is strictly prohibited and =ay be unlawful. If you have received this communication in error, pleas= notify us immediately by return e-mail or by e-mail to [email protected], andar>destroy this communication and all copies thereof, including all atta=hments. copyright -all rights reserved 3 EFTA_R1_01779013 EFTA02594856